Top Markets
#1 龙虾 (Lobster) 龙虾 (Lobster) +117.81%
#2 Lisk Lisk +81.56%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +30.37%
#4 Tokenlon Tokenlon +28.92%
#5 Alchemist AI Alchemist AI +28.02%
#6 Nockchain Nockchain +25.68%
#7 earnAUSD earnAUSD +24.75%
#8 Renzo Renzo +21.89%
#9 Illuvium Illuvium +19.74%
#10 Akedo Akedo +18.38%
Coin of the day
龙虾 (Lobster) 龙虾 (Lobster)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Rangering i aksjer #41009
MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm,... MultiCell Technologies, Inc. (MCET) operates as a biopharmaceutical firm, primarily focused on the creation of innovative therapeutic agents and research tools. Their efforts are directed towards addressing a range of medical challenges, including neurological conditions, liver ailments, various types of cancer, and applications within interventional cardiology and peripheral vascular health. The company's product pipeline features several key developments: MCT-125: This investigational therapy is currently in Phase II clinical trials, targeting the primary fatigue commonly associated with multiple sclerosis. MCT-465: A preclinical-stage synthetic double-stranded RNA (dsRNA) candidate, designed to act as a powerful immune enhancer for the treatment of solid tumor malignancies. MCT-485: Another dsRNA therapeutic, still in the discovery phase, which demonstrates tumor cytolytic (cell-destroying) properties, intended for use against diverse cancers. Beyond drug candidates, MultiCell Technologies is also progressing the Ideal BioStent, an innovative bioabsorbable stent specifically engineered for use in interventional cardiology and peripheral vessel procedures. The organization maintains licensing agreements with prominent entities such as Corning Incorporated and Pfizer Inc. Established in 1962, the company was previously known as Exten Industries, Inc. before officially changing its name to MultiCell Technologies, Inc. in April 2004. Its corporate headquarters are situated in Woonsocket, Rhode Island.
Aksjekurs
$0.00001
Sist synkronisert: 2026-09-10
Markedsverdi
$50.01K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel MultiCell Technologies, Inc. (MCET)

Kategori

Healthcare
Antall utestående aksjer for MultiCell Technologies, Inc. (MCET)
Antall utestående aksjer per August 2015: 5.14M
Ifølge MultiCell Technologies, Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 5.14M. Ved slutten av November 2013 hadde selskapet 1.92M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for MultiCell Technologies, Inc. (MCET) fra 2013 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 5.14M 37.91%
2014 3.73M 94.37%
2013 1.92M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 4,840.99%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,110.15%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 7,606.31%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 9,219.81%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH